chrX-38412001-T-C
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PVS1_StrongPM2PP5_Moderate
The NM_000531.6(OTC):c.1005+2T>C variant causes a splice donor, intron change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_000531.6 splice_donor, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
OTC | NM_000531.6 | c.1005+2T>C | splice_donor_variant, intron_variant | Intron 9 of 9 | ENST00000039007.5 | NP_000522.3 | ||
OTC | NM_001407092.1 | c.1005+2T>C | splice_donor_variant, intron_variant | Intron 11 of 11 | NP_001394021.1 | |||
OTC | XM_017029556.2 | c.*140T>C | downstream_gene_variant | XP_016885045.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
OTC | ENST00000039007.5 | c.1005+2T>C | splice_donor_variant, intron_variant | Intron 9 of 9 | 1 | NM_000531.6 | ENSP00000039007.4 | |||
ENSG00000250349 | ENST00000465127.1 | c.172-254120T>C | intron_variant | Intron 3 of 8 | 5 | ENSP00000417050.1 | ||||
OTC | ENST00000643344.1 | n.*755+2T>C | splice_donor_variant, intron_variant | Intron 10 of 10 | ENSP00000496606.1 |
Frequencies
GnomAD3 genomes Cov.: 22
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 22
ClinVar
Submissions by phenotype
Ornithine carbamoyltransferase deficiency Pathogenic:1
In silico splice prediction tools (ASSP and NNSPLICE) suggest that this variant might affect splicing due to the loss of essential donor site and introduction of a new splice site, which in turn might lead to a frameshift and consequent premature termination of the protein; this will likely result in loss-of-function. This variant (also known as IVS9+2T>C) was previously reported as a deleterious mutation in association with acute neonatal hyperammonemia. In addition, all the mutations in consensus splicing sites identified in the study including IVS9+2T>C, are reported to confer a neonatal phenotype [PMID: 11793468]. -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at